Fresenius Medical Care AG
FMS
$22.10
-$0.12-0.54%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.29B | 5.90B | 5.71B | 5.44B | 5.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.29B | 5.90B | 5.71B | 5.44B | 5.14B |
| Cost of Revenue | 3.94B | 4.29B | 4.26B | 4.06B | 3.89B |
| Gross Profit | 1.35B | 1.62B | 1.45B | 1.38B | 1.25B |
| SG&A Expenses | 859.47M | 913.38M | 824.74M | 898.84M | 789.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 19.15M | -31.32M | -3.14M | -11.50M | 8.51M |
| Total Operating Expenses | 4.86B | 5.21B | 5.12B | 4.99B | 4.74B |
| Operating Income | 430.98M | 689.18M | 586.57M | 447.62M | 401.71M |
| Income Before Tax | 238.14M | 591.90M | 470.65M | 397.85M | 263.77M |
| Income Tax Expenses | 49.06M | 123.91M | 87.95M | 88.82M | 64.24M |
| Earnings from Continuing Operations | 189.08M | 467.99M | 382.70M | 309.04M | 199.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.21M | -87.24M | -61.43M | -53.37M | -40.40M |
| Net Income | 134.87M | 380.75M | 321.27M | 255.67M | 159.14M |
| EBIT | 430.98M | 689.18M | 586.57M | 447.62M | 401.71M |
| EBITDA | 835.20M | 908.19M | 997.91M | 844.03M | 797.70M |
| EPS Basic | 0.49 | 1.33 | 1.10 | 0.87 | 0.54 |
| Normalized Basic EPS | 0.67 | 1.07 | 0.95 | 0.66 | 0.63 |
| EPS Diluted | 0.49 | 1.33 | 1.10 | 0.87 | 0.54 |
| Normalized Diluted EPS | 0.67 | 1.07 | 0.95 | 0.66 | 0.63 |
| Average Basic Shares Outstanding | 275.25M | 285.91M | 292.10M | 293.41M | 293.41M |
| Average Diluted Shares Outstanding | 275.25M | 285.91M | 292.10M | 293.41M | 293.41M |
| Dividend Per Share | -- | 1.73 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 187.56% | -- |